Detail

Keywords

Amino Acids, Branched-Chain; DNA Methylation; Epigenetic Repression; Fatty Liver; Metabolomics; miRNA; Obesity; Pediatric Obesity; Pediatrics

Research interests

Dr. Julia Lischka, PhD, started her career in research focusing on childhood obesity in 2017 at the Department of Pediatrics, Medical University of Vienna, in the laboratory of the “Research Core Unit for Inflammation & Metabolism”.
Her reseach focuses on metabolic and epigenetic markers associated with inflammation and obesity-associated metabolic comorbidities as well as lipid metabolism disorders, particularly familial hypercholesterolemia.

Selected publications

1. Lischka, J. et al. (2022) ‘Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity’, Nutrients, 14(2), p. 286. Available at: http://dx.doi.org/10.3390/nu14020286.
2. Lischka, J. et al. (2021) ‘Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patients’, International Journal of Obesity, 45(8), pp. 1763–1772. Available at: http://dx.doi.org/10.1038/s41366-021-00842-1.
3. Lischka, J. et al. (2020) ‘A branched‐chain amino acid‐based metabolic score can predict liver fat in children and adolescents with severe obesity’, Pediatric Obesity, 16(4). Available at: http://dx.doi.org/10.1111/ijpo.12739.
4. Baumgartner M, Lischka J et al. (2022) ‘Plasma Myostatin Increases with Age in Male Youth and Negatively Correlates with Vitamin D in Severe Pediatric Obesity’, Nutrients, 14(10), p. 2133. Available at: http://dx.doi.org/10.3390/nu14102133.
5. Lischka, J. et al. (2022) ‘Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia’, BMC Pediatrics, 22(1). Available at: http://dx.doi.org/10.1186/s12887-022-03192-7.